Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Medicilon-Inc

More Like This

Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence

PR Newswire associated0

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs

PR Newswire associated0

Medicilon Expands Global Presence with Official Opening of Second R&D Center in Massachusetts

PR Newswire associated0

Medicilon Appoints Dr. Lilly Xu as Chief Technology Officer

Business Wire logo

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

PR Newswire associated0

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

Mycenax and RIN Sign License Agreement to Advance ADC Development Using RIN's Proprietary Linker Technology

Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights